Company Overview and News

 
Aeris Resources puts pedal to the metal with robust financial position providing growth

2018-05-01 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) is poised to finish fiscal 2018 on a high, recently confirming that it was on track to meet annual copper production guidance of 27,000 tonnes.

 
Argonaut Resources raises $5.5 million to progress Torrens iron oxide copper-gold project

2018-04-23 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has completed a private share placement, raising $5.5 million at an issue price of 2 cents.

 
Argonaut Resources prepares to raise capital as it progresses Nyungu cobalt-copper deposit

2018-04-19 proactiveinvestors.com.au
The company is about to make an announcement regarding a capital raising, the details of which should be available by early next week.

 
Argonaut Resources prepares to raise capital as it progresses Nyungu cobalt-copper deposit

2018-04-19 proactiveinvestors.com.au
The company is about to make an announcement regarding a capital raising, the details of which should be available by early next week.

 
Argonaut Resources prepares to upgrade cobalt deposit in Zambia

2018-04-06 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) is planning follow-up drilling at the Nyungu copper-cobalt deposit in Zambia to increase cobalt and copper tonnages.

 
Argonaut Resources has market's attention with Olympic Dam style target

2018-03-20 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has an expansive project portfolio prospective for copper, cobalt, lithium and gold across Australia and Zambia in Africa.

 
Argonaut Resources has markets attention with Olympic Dam style target

2018-03-20 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has an expansive project portfolio prospective for copper, cobalt, lithium and gold across Australia and Zambia in Africa.

 
Aeris Resources has potential to strengthen its copper portfolio following go-ahead for Lake Torrens

2018-03-19 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) is a beneficiary of a federal court ruling which dismissed appeals by three groups relating to the proposed Lake Torrens project in South Australia.

 
Argonaut Resources confirms favourable court decision for Lake Torrens title rights

2018-03-19 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) is getting ready to resume drilling at the Torrens joint venture near Olympic Dam in South Australia, following a favourable decision by the full federal court.

 
Aeris gains final approval on Torrens copper JV in South Australia

2018-02-20 australianmining.com.au
Aeris Resources has received approval from the South Australian Minister for Aboriginal Affairs and Reconciliation, meaning its Torrens copper-gold joint venture (JV) in the Stuart Shelf region can go ahead. Aeris is primarily known for its Tritton copper mine, which reached 10 years of production in 2015.

 
'The shackles are off Torrens' as Argonaut Resources receives final approval for drill program

2018-02-19 proactiveinvestors.com.au
Lindsay Owler, chief executive at Argonaut Resources NL (ASX:ARE), tells Proactive's Andrew Scott they've received the final approval required for a major drilling program at the Torrens project in South Australia.

 
Argonaut Resources surges 28% on final approval for major Torrens drilling program

2018-02-19 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) surged 28% on opening after receiving the final approval required for a major drilling program at the Torrens project in South Australia.

 
Argonaut Resources enters trading halt regarding material update

2018-02-15 proactiveinvestors.com.au
The halt was requested due to the release of upcoming information regarding the outcome of an application by the Torrens Joint Venture under the South Australian Aboriginal Heritage Act.

 
Argonaut Resources issues 1 million shares after exercising options

2018-02-14 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has issued more than 1 million shares for a total value of $6000 after exercising options.

 
Argonaut Resources director exercises in-the-money options

2018-01-15 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) independent, non-executive director Malcolm Richard has demonstrated his confidence in the company with the exercise of 3.2 million options.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...